You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils

À propos des lignes directrices

Displaying Guidelines

361 articles

Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology–Cancer Care Ontario Focused Guideline Update

Document Status: Current
ID: GL-1-A-2016-2

Oct 2017

Safe Administration of Chemotherapy: Methods and Development

Document Status: In-Review
ID: 12-12M

Jul 2012

Safe Administration of Chemotherapy: Safety During Chemotherapy Ordering, Transcribing, Dispensing, and Patient Identification

Document Status: In-Review
ID: 12-12-1

Jul 2012

Safe Administration of Systemic Cancer Therapy Part 2: Administration of Systemic Treatment and Management of Preventable Adverse Events

Document Status: In-Review
ID: 12-12-2
Version: 2

Nov 2018

Safety Considerations for the Implementation of Subcutaneous Rituximab Formulation

Document Status: Current
Version: 1

Jun 2018

Second-line or Subsequent Systemic Therapy for Recurrent or Progressive Non-Small Lung Cancer

Document Status: Archived
ID: 7-19

Oct 2012

Self-Management Education for Patients with Cancer: Evidence Summary

Document Status: Archived
ID: 20-3

Jan 2016

Self-Management in Cancer: Quality Standards

Document Status: Current
ID: N/A
Version: 1

Nov 2018

Single-Agent Interleukin-2 in the Treatment of Metastatic Melanoma

Document Status: Archived
ID: 8-5
Version: 2

Sep 2011

Sorafenib for Advanced Hepatocellular Carcinoma

Document Status: Archived
ID: CED 7

Feb 2008

Staging and Surgical Approaches in Gastric Cancer

Document Status: Current
ID: 2-19

Jan 2017

Stem Cell Transplantation in Adults

Document Status: Archived
ID: SCT

Jan 2009